In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

  • Stefanie K. Menzies*
  • , Rachel H. Clare
  • , Chunfang Xie
  • , Adam Westhorpe
  • , Steven R. Hall
  • , Rebecca J. Edge
  • , Jaffer Alsolaiss
  • , Edouard Crittenden
  • , Amy E. Marriott
  • , Robert A. Harrison
  • , Jeroen Kool
  • , Nicholas R. Casewell
    • *Corresponding author for this work

Research output: Contribution to journal › Article (journal) › peer-review

26   Link opens in a new tab Citations (Scopus)
36 Downloads (Pure)

Fingerprint

Dive into the research topics of 'In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science